MERCK KGAA

MERCK KGAA

• Higher prices for MS drug help drug firm Merck

  Higher prices for its multiple sclerosis drug Rebif helped German pharmaceutical and high-tech materials company Merck KGaA post a 54 percent rise in ... 

• Merck Q4 net profit more than doubles

  Merck KGaA saw its profit more than double in the fourth quarter as the German pharmaceutical company benefited from higher prices for its Rebif ... 

• Germany's Merck suffers setback with cancer drug

  German pharmaceutical company Merck KgaA says a late stage trial of a new lung cancer drug has failed to meet expectations. The company, based in ...